Primary Antibodies

Recombinant protein fragment of Human CD164L2 with N-terminal His6ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) fusion tag. Application Suitable as a blocking agent using corresponding antibodies.

Recombinant protein fragment of Human CD177&nbspwith&nbspN-terminal His 6 ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) fusion tag.&nbsp &nbsp&nbsp Application Blocking agent and positive assay control using

Recombinant protein fragment of Human CD177&nbspwith&nbspN-terminal His 6 ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) fusion tag.&nbsp &nbsp&nbsp Application Blocking agent and positive assay control using

N-terminal His 6 ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) Application Suitable as a blocking agent and positive assay control using corresponding antibodies. Linkage Corresponding Antibodies HPA077640 Physical form

PrEST Antigen CD177 CD177 molecule, 100ul UN 1687 6.1 PG2

PrEST Antigen CD177 CD177 molecule, 100ul UN 1687 6.1 PG2

Recombinant protein fragment of Human CD1A with N-terminal His6ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) fusion tag. Application Suitable as a blocking agent using corresponding antibodies.

PrEST Antigen CD1A CD1a molecule, 100ul UN 1687 6.1 PG2

Recombinant protein fragment of Human CD1B with N-terminal His6ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) fusion tag. Application Suitable as a blocking agent using corresponding antibodies.

Recombinant protein fragment of Human CD1D&nbspwith&nbspN-terminal His 6 ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) fusion tag.&nbsp &nbsp&nbsp Application Blocking agent and positive assay control using

PrEST Antigen CD1D CD1d molecule, 100ul UN 1687 6.1 PG2

Recombinant protein fragment of Human CD1E with N-terminal His6ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) fusion tag. Application Suitable as a blocking agent using corresponding antibodies.